Related Experiment Video
Updated: Aug 6, 2026

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin
Published on: March 24, 2023
Tuberous sclerosis
1Department of Medical Genetics, University of Cambridge, Cambridge, UK. jrwy1@cam.ac.uk
Abstract:
Tuberous sclerosis is a serious inherited disease which poses major challenges for affected families and those caring for them. Identification of the genes causing the condition and study of their protein products has shed light on the pathogenesis of the disease and provided valuable new information about signalling pathways regulating protein synthesis and cell growth. There is now the exciting possibility of drug therapy for some of the manifestations of the disease.
Insights
Tuberous sclerosis, an inherited disease, presents challenges for families. Gene identification and protein studies illuminate its pathogenesis and offer hope for new drug therapies for manifestations.
Area of Science:
- Genetics and Molecular Biology
- Cellular Signaling Pathways
- Inherited Disease Pathogenesis
Background:
- Tuberous sclerosis is a significant inherited disorder impacting families and caregivers.
- Understanding the genetic basis and molecular mechanisms is crucial for managing the disease.
Purpose of the Study:
- To elucidate the pathogenesis of tuberous sclerosis through gene and protein product analysis.
- To explore novel therapeutic strategies for the disease's manifestations.
Main Methods:
- Identification of causative genes for tuberous sclerosis.
- Analysis of the function of identified protein products.
- Investigation of signaling pathways involved in protein synthesis and cell growth.
Main Results:
- Genetic and proteomic studies have illuminated the disease's pathogenesis.
- New insights into signaling pathways regulating protein synthesis and cell growth have been obtained.
Conclusions:
- The study provides a foundation for understanding tuberous sclerosis at a molecular level.
- There is a promising potential for developing targeted drug therapies for specific manifestations of tuberous sclerosis.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Huntington Disease l: Introduction
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Drugs that Stabilize Microtubules
